Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.

Farley JH, Tian C, Rose GS, Brown CL, Birrer M, Maxwell GL. Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials. Cancer. 2009 Sep 15; 115(18):4210-7.

View in: PubMed

subject areas

Aged
Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Drug Administration Schedule
Female
Health Status Disparities
Humans
Middle Aged
Minority Health
Ovarian Neoplasms
Paclitaxel
Randomized Controlled Trials as Topic
Treatment Outcome

authors with profiles

Michael Birrer